Study Comparing a Cohort of Women Having a Classic Caesarean to a Cohort of Women Having a FAUCS Caesarean (FAUCS) (FAUCS)

September 13, 2022 updated by: Ramsay Générale de Santé

Prospective Multicenter Study Comparing a Cohort of Women Having a Classic Caesarean to a Cohort of Women Having a FAUCS Caesarean

The main objective of this study is to compare the time taken to obtain "street fitness" status for women after extraperitoneal cesarean section compared to women after a classic cesarean section.

Study Overview

Status

Recruiting

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

72

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • IDF
      • Versailles, IDF, France, 78000
        • Recruiting
        • Les Franciscaines Clinic
        • Contact:
          • Bénédicte Simon

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 42 years (ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Patient scheduled for a caesarean between 38 and 42 weeks pregnant
  • Patient aged between 18 and 42 years old
  • Singleton
  • Caesarean section with a theoretical operating time < 1 hour (without major complications)
  • Patient affiliated to a social security scheme
  • Patient having signed the free and informed consent.

Exclusion Criteria:

  • BMI > 40
  • High blood pressure treated intravenously
  • Pre-existing diabetes in pregnancy
  • Allergy to analgesics
  • Prenatal depression
  • Pathological insertion of the placenta (placenta previa or accreta).
  • History of major pelvic or abdominal surgery (myomectomy, peritonitis) other than caesarean section or minor surgery.
  • Addiction (drugs)
  • Pre-existing psychiatric pathology leading to a risk of impaired judgment or behavior.
  • Patient participating in another clinical study with a drug or medical device
  • Protected patient: Adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision
  • Patient hospitalized without consent.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: OTHER
  • Allocation: NON_RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Patient with intraperitoneal caesarean section
Two different caesarean section techniques : intra or extraperitoneal
EXPERIMENTAL: patient with extraperitoneal caesarean section
Faucs technique
Two different caesarean section techniques : intra or extraperitoneal

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The postoperative time in hours from which the patient stably fulfills the criteria for "street fitness".
Time Frame: 1 month
These criteria are defined in the Chung score. This score is between 0 and 10 and evaluate the vital signs, wandering, nausea or vomits, pain and surgical bleeding.
1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

December 27, 2021

Primary Completion (ANTICIPATED)

September 27, 2022

Study Completion (ANTICIPATED)

July 27, 2023

Study Registration Dates

First Submitted

September 8, 2022

First Submitted That Met QC Criteria

September 8, 2022

First Posted (ACTUAL)

September 13, 2022

Study Record Updates

Last Update Posted (ACTUAL)

September 15, 2022

Last Update Submitted That Met QC Criteria

September 13, 2022

Last Verified

September 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 2019-A01220-57

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cesarean Section; Dehiscence

Clinical Trials on Caesarean

Subscribe